CircuLite (Saddlebrook, New Jersey) reported that it has received conditional approval from the FDA of an IDE for its lead product, the Synergy Circulatory Support System, a minimally-invasive device designed to reverse the symptoms of heart failure in ambulatory chronic heart failure patients.

Scientists have known for years that heat dramatically increases the effectiveness of chemotherapy but the challenge has been figuring out how to selectively heat the cancer cells without also affecting healthy tissue. A couple years ago a group of entrepreneurs founded a company, Actium BioSystems (Boulder, Colorado), to take on this challenge and invent a selective-heating technology to combine the clinical benefits of heat (hyperthermia) and chemotherapy.